FORMATION OF AMYLOID-LIKE SUBSTANCE FROM BETA-2-MICROGLOBULIN IN-VITRO - ROLE OF SERUM AMYLOID-P COMPONENT - A PRELIMINARY-STUDY

被引:26
作者
ONO, K [1 ]
UCHINO, F [1 ]
机构
[1] YAMAGUCHI UNIV,SCH MED,DEPT PATHOL 1,UBE,YAMAGUCHI 755,JAPAN
来源
NEPHRON | 1994年 / 66卷 / 04期
关键词
BETA-2-MICROGLOBULIN; AMYLOID; GLYCOSAMINOGLYCAN; AMYLOID-P COMPONENT; SERUM;
D O I
10.1159/000187854
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Although the pathogenesis has yet to be fully understood, beta2-microglobulin (beta2m) related amyloidosis is a frequent complication in long-term hemodialysis (HD) patients. In an attempt to clarify the association of two potentia candidates with amyloidogenesis from beta2m in HD patients, human urine-derived beta2m solution alone or combined with glycosaminoglycans: hyaluronic acid, heparan sulfate, or serum amyloid P component (SAP) were dialyzed against physiological buffered solution (pH 7.4) using a microdialyzer in vitro for 72 h at 4-degrees-C. This study demonstrates for the first time that SAP can play a crucial role in the formation of amyloid-like fibrils from beta2m. This occurs by a direct influence on either the processing of a precursor protein, or protein folding, in vitro, by a short-period dialysis against a physiological buffered solution.
引用
收藏
页码:404 / 407
页数:4
相关论文
共 12 条
[1]  
ATHANASOU NA, 1991, Q J MED, V78, P205
[2]  
CAMPISTOL JM, 1992, AM J PATHOL, V141, P241
[3]   DEMONSTRATION OF PLASMA PROTEINASE-INHIBITORS IN BETA-2-MICROGLOBULIN AMYLOID DEPOSITS [J].
CAMPISTOL, JM ;
SHIRAHAMA, T ;
ABRAHAM, CR ;
RODGERS, OG ;
SOLE, M ;
COHEN, AS ;
SKINNER, M .
KIDNEY INTERNATIONAL, 1992, 42 (04) :915-923
[4]   AMYLOIDOSIS AND FEMALE PROTEIN IN THE SYRIAN-HAMSTER - CONCURRENT REGULATION BY SEX-HORMONES [J].
COE, JE ;
ROSS, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (04) :1257-1267
[5]   INVITRO FORMATION OF AMYLOID FIBRILS FROM INTACT BETA-2-MICROGLOBULIN [J].
CONNORS, LH ;
SHIRAHAMA, T ;
SKINNER, M ;
FENVES, A ;
COHEN, AS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 131 (03) :1063-1068
[6]  
HAWKINS PN, 1988, LANCET, V1, P1413
[7]   AMYLOID SYNDROMES ASSOCIATED WITH HEMODIALYSIS [J].
KLEINMAN, KS ;
COBURN, JW .
KIDNEY INTERNATIONAL, 1989, 35 (02) :567-575
[8]   DIALYSIS-RELATED AMYLOIDOSIS [J].
KOCH, KM ;
GENNARI, FJ ;
VANYPERSELE, C ;
REES, A ;
GOLDMAN, M ;
MIHATSCH, MJ ;
MION, CM ;
BORSATTI, A ;
WINEARLS, CG ;
DAVISON, AM ;
COHEN, JJ ;
MADIAS, NE ;
OLMER, M ;
HARRINGTON, JT ;
BAGGIO, B ;
RAMBAUSEK, MH ;
DONOHOE, JF ;
VANES, LA .
KIDNEY INTERNATIONAL, 1992, 41 (05) :1416-1429
[9]  
ONO K, 1991, JPN J DIAL TREAT, V24, P1447
[10]  
PEPYS MB, 1988, Q J MED, V67, P283